News

Ketamine, long used as an anesthetic or illegal party drug, is being combined with psychotherapy to treat severe depression and post-traumatic stress.

An intensive two-day Yale Cancer Research symposium, dedicated to advancing cancer science through innovation and strengthening partnerships between Yale University and Historically Black Colleges and Universities (HBCUs), brought together researchers from multiple disciplines this week.

October is Breast Cancer Awareness Month. Dr. Eric Winer, the director of Yale Cancer Center and president and physician-in-chief of Smilow Cancer Hospital, discussed the latest advancements in breast cancer research, treatment, and prevention with News 8.

A brain network linked to social attention is functional in newborns, a Yale study finds. It may underlie some of the social vulnerabilities associated with autism.

Treatment-resistant does not mean untreatable. Discover the evidence-based options for coping with this form of depression.

The Office of Research on Women’s Health and National Institute on Alcohol Abuse and Alcoholism has awarded a U54 Specialized Center of Research Excellence (SCORE) grant to the Yale-SCORE investigative team.

Fluctuations in brain activity increase until mid-adolescence. Deviations from this trajectory are linked to worse executive functioning.

Nakul Ravi Raval, PhD, postdoctoral associate, has been awarded a K99/R00 grant from the National Institute on Alcohol Abuse and Alcoholism for the study, “Novel GluN2BR Radioligand for PET Neuroimaging in Alcohol Use Disorder.”

Physicians who perform procedures on patients and conduct research have a unique perspective that drives medical innovation. Team science supports their work in both areas.